Trial set for drugmaker accused of profiting from government patents
Washington Post
The U.S. government claims Gilead Sciences has made billions of dollars by capitalizing on an anti-HIV regimen patented by the CDC, while the drugmaker argues the patents are invalid.
https://www.washingtonpost.com/business/2023/05/02/gilead-hiv-cdc/